Depressive Disorder, Major Clinical Trial
Official title:
Evaluation of Clinical and Suicidal Behavior Characteristics Among Urban, Turkish Middle-Age Depressive Patients With Comorbid Adult Attention Deficit Hyperactivity Disorder
In the presence of attention deficit hyperactivity disorder (ADHD) together with additional psychiatric diseases, the treatment process and prognosis of both ADHD and psychiatric comorbidity are adversely affected. The aim of this study is to compare the characteristics concerning the suicidal behavior of the patients with major depressive disorder (MDD) who have (ADHD+) or do not have (ADHD-) adult ADHD comorbidity and their responses to depression treatment. 96 inpatients were included in the study. Socio-demographic data form, Hamilton Depression Scale (HDRS), Wender Utah Rating Scale (WURS), Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale (A-ADHD), Personal and Social Performance Scale (PSP) were applied to the cases. In the study, depression starts at an early age in individuals with comorbid ADHD and the depression treatment progress changes negatively. This group of patients is at greater risk in terms of suicidal behavior. For these reasons, clinicians should be careful during ADHD and depression management in adults.
Suicidal behavior is a serious cause of mortality and morbidity in terms of psychiatric
diseases. Suicidal ideation and suicide attempts that do not result in death cause many
social and emotional problems, but they are the most important risk factors for the next
suicide attempt and death resulting from suicide.[1,2] It has been reported that 90% of the
completed suicide attempt cases are accompanied by a psychiatric disease and depressive
disorders are seen at a highest level. [3] Attention-deficit hyperactivity disorder (ADHD) is
a neurodevelopmental disorder with symptoms of inattention, hyperactivity and impulsivity
that is seen as of childhood.[4-6] ADHD disrupts the individuals' functionality in many
fields such as academic, social and business life.[7] It also increases the risk of
comorbidity of many psychiatric diseases.[8-10] In the studies carried out, it has been
reported that depression is seen in rates ranging from 16% to 31% in cases with adult ADHD
[11] and it was accompanied by ADHD in 15% of cases with depression.[12] In depressive adults
with ADHD comorbidity, resistance to depression treatment develops and the longitudinal
progress of both diseases is adversely affected.[13-14] In the literature review, it has been
reported that suicide risk increased in children,[15] in university students,[16] in young
women,[17] in ADHD and depression comorbidity and the clinical progress of depression was
adversely affected.[18] Studies examining the relationship of suicide in ADHD and depression
comorbidity in adults have been mostly carried out in young adults and it has been suggested
by researchers to investigate the association of ADHD and depression in older adults.[19-22]
The aim of this study was to compare the suicidal behavior, the onset age of depression and
the respond to the treatment of the depressive disorder inpatients in the psychiatry service
who are with and without comorbid ADHD. Hypothesis of this study is that the following will
be observed in the adult depression patients with ADHD comorbidity; depression starting at an
earlier age, having much more suicide attempts (number of suicide attempts in the past) that
are much serious (requiring medical treatment) and having more severe depression (depression
scale scores) and worse self-functionality during discharge from the hospital.
Material & Methods Complying with DSM-IV criteria and Hamilton Depression Scale (HDRS) being
over 16 points during hospitalization have been determined to be the criteria for inclusion
in the research. In total, 96 patients were included in the study. All cases were interviewed
with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I).[23] Other
comorbid psychiatric disorders were excluded. Adult ADHD diagnosis has been confirmed by two
different researchers for each case (DHD, EE). In the retrospective investigation of ADHD
diagnosis, cases who got the score of 36 and above in the Wender Utah Rating Scale (WURS)
have been included in the study.
Investigators evaluated suicidal behavior in a similar manner to the methods used in some
previous studies.[20,24,25] In the sociodemographic data form, suicidal ideation in the past
(Have you ever thought about ending your life before? / Yes or No), suicide attempt (Have you
ever attempted suicide before? / Yes or No) and number of suicide attempts have been
recorded. Material
Socio-demographic data form:
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) [26] Hamilton Depression
Rating Scale (HDRS): [28] Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale
(A-ADHDS) has been developed by Atilla Turgay in Canada.[29,30] Wender Utah Rating Scale
(WURS): [31,32] Personal and Social Performance Scale (PSP): [33,34] Statistical analysis:
SPSS Statistics Version 22.0 has been used for data analysis. The distribution
characteristics of the variables have been evaluated by using the Shapiro-Wilk test.
Student-t test has been used to compare normal distribution parameters and Mann-Whitney U
test has been used for abnormal distribution parameters. According to the ADHD comorbidity,
suicide attempt has been compared with the Pearson chi-squared test. P values below 0.05 have
been considered to be statistically significant results.
Results The mean age of the patients was 39.1±10.4. 57% (n=55) of all patients were females.
31% (n=30) were single / never married, 53% (n=49) were married / living with a spouse, 16%
(n=17) were divorced or living apart There was no statistically significant difference found
between patients with ADHD comorbidity (ADHD+) and patients with only MDD (ADHD-) in terms of
gender, age, marital status and education.
In the ADHD+ group, depression started at an earlier age than the ADHD- group (p= .011). The
average HDRS scores during admission to hospital and discharge from the hospital were
significantly higher in the ADHD+ group (p<.000). Moreover, the average PSP scores of the
ADHD+ group at admission to hospital was lower than the ADHD- group and there was a
statistically significant difference between them (p = .002). There was no difference between
the groups during their discharge with regards to PSP scores (p = .46).
Suicidal ideation (p = .018) and suicide attempts (p = .013) throughout life were higher in
the ADHD+ group than the ADHD- group. In the ADHD+ group, the rate of suicide attempts that
require medical intervention was higher (p = .001). A comparison of the suicidal behavior
characteristics of ADHD+ and ADHD- groups is presented in Table 3 and it has been shown
graphically whether the cases have attempted suicide according to ADHD comorbidity throughout
their lives.
Discussion n ADHD+ group, depression has started at an earlier age, the severity of
depression has been higher during discharge from the hospital and suicidal ideation, number
of suicide attempts and suicide attempts requiring medical intervention throughout their
lives were found to be high. Depressive disorder patients with ADHD comorbidity in our study
have got their first depression diagnosis at an early age. Similar results have been found by
other researchers.[17,35, 36] Another result of study was that the discharge HDRS scores of
the depressive patients with ADHD comorbidity were higher. Resistance to depression treatment
has been reported in the association of ADHD and depression.[38,39] ADHD causes disruptions
of the individuals' functionality in many areas of their lives starting from childhood
[40,41] and it has also been reported that there is a decrease in social skills and
self-esteem of adolescents with ADHD.[42] It has been suggested that in the event of frequent
recurrent depressive attacks, inability of remission, continuation of residual symptoms and
inadequate response to classical therapies of cases with depression, a retrospective
investigation of ADHD[38,39] and treatment planning for ADHD should be made.[18,36,43] As a
result of the study, the rate of suicidal ideation throughout life and number of suicide
attempts were found to be higher in ADHD+ group. As mentioned literature, 90% of the cases
who attempted suicide are accompanied by a psychiatric disorder where depressive disorder is
the most common one.[3] It has been reported that suicide attempts are related to depression
duration or impulsivity.[43] In addition, as a result of the research, in the association of
ADHD and depression, the number of suicidal behaviors that are serious enough to require
medical care is also higher. This finding has also been reported by other researchers when
literature is evaluated.[16,25] In adults, suicide is more common in ADHD and MDD comorbidity
and suicidal attempts may lead to more dangerous consequences (such as being in the intensive
care unit, causing disability).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05988333 -
Psychoeducational Intervention for Families With a Member Affected by Major Depression
|
N/A | |
Completed |
NCT02919501 -
Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
|
Phase 2 | |
Completed |
NCT00976560 -
Clinical Study to Test a New Drug to Treat Major Depression
|
Phase 2 | |
Recruiting |
NCT05518149 -
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
|
Phase 3 | |
Not yet recruiting |
NCT06303076 -
Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial
|
Phase 4 | |
Not yet recruiting |
NCT05901571 -
Acupuncture and Escitalopram for Treating Major Depression Clinical Study
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Suspended |
NCT02546024 -
Predictors of Treatment Response in Late-onset Major Depressive Disorder
|
N/A | |
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01583400 -
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
|
N/A | |
Completed |
NCT01152996 -
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
|
Phase 3 | |
Enrolling by invitation |
NCT00762866 -
Psychiatric Genotype/Phenotype Project Repository
|
||
Completed |
NCT00384033 -
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT00366652 -
Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
|
Phase 3 | |
Completed |
NCT00369343 -
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
|
Phase 3 | |
Completed |
NCT00149643 -
Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
|
Phase 2 | |
Completed |
NCT00316160 -
Sexual Functioning Study With Antidepressants
|
Phase 4 |